全文获取类型
收费全文 | 267837篇 |
免费 | 21974篇 |
国内免费 | 8779篇 |
专业分类
耳鼻咽喉 | 1977篇 |
儿科学 | 5039篇 |
妇产科学 | 3760篇 |
基础医学 | 41170篇 |
口腔科学 | 5146篇 |
临床医学 | 19215篇 |
内科学 | 48255篇 |
皮肤病学 | 3893篇 |
神经病学 | 20067篇 |
特种医学 | 6406篇 |
外国民族医学 | 59篇 |
外科学 | 21191篇 |
综合类 | 33229篇 |
现状与发展 | 26篇 |
一般理论 | 6篇 |
预防医学 | 14049篇 |
眼科学 | 2787篇 |
药学 | 39650篇 |
73篇 | |
中国医学 | 10538篇 |
肿瘤学 | 22054篇 |
出版年
2023年 | 4807篇 |
2022年 | 10807篇 |
2021年 | 13065篇 |
2020年 | 9926篇 |
2019年 | 9822篇 |
2018年 | 9445篇 |
2017年 | 8760篇 |
2016年 | 8440篇 |
2015年 | 9622篇 |
2014年 | 15052篇 |
2013年 | 16720篇 |
2012年 | 14202篇 |
2011年 | 16459篇 |
2010年 | 13447篇 |
2009年 | 13859篇 |
2008年 | 13401篇 |
2007年 | 12211篇 |
2006年 | 11005篇 |
2005年 | 9693篇 |
2004年 | 8275篇 |
2003年 | 7397篇 |
2002年 | 5890篇 |
2001年 | 4839篇 |
2000年 | 4224篇 |
1999年 | 3786篇 |
1998年 | 3370篇 |
1997年 | 3153篇 |
1996年 | 2835篇 |
1995年 | 2473篇 |
1994年 | 2228篇 |
1993年 | 1868篇 |
1992年 | 1556篇 |
1991年 | 1482篇 |
1990年 | 1208篇 |
1989年 | 1028篇 |
1988年 | 1002篇 |
1987年 | 825篇 |
1986年 | 766篇 |
1985年 | 2117篇 |
1984年 | 2844篇 |
1983年 | 1872篇 |
1982年 | 2030篇 |
1981年 | 1835篇 |
1980年 | 1545篇 |
1979年 | 1345篇 |
1978年 | 1119篇 |
1977年 | 929篇 |
1976年 | 1044篇 |
1975年 | 744篇 |
1973年 | 691篇 |
排序方式: 共有10000条查询结果,搜索用时 15 毫秒
131.
Flavia Temperilli Aldona Rina Isabella Massimi Anna Lisa Montemari Maria Luisa Guarino Alessandra Zicari 《Platelets》2015,26(8):783-787
Serum thromboxane-B2 (TxB2), together with arachidonic acid (AA)-induced platelet aggregation, are, at the moment, the most used tests to identify patients displaying high on-aspirin treatment platelet reactivity (HAPR). Both tests are specific for aspirin action on cyclooxygenase-1. While the correlation between serum TxB2 assay and clinical outcome is established, data are conflicting with regard to aspirin treatment and a possible association with AA-stimulated platelet markers and clinical outcome. To understand such discrepancy, we performed a retrospective study to compare both assays. We collected data from 132 patients receiving a daily dose of aspirin (100?mg/day) and data from 48 patients receiving aspirin on alternate days. All Patients who received a daily dose of aspirin were studied for AA-induced platelet aggregation together with serum TxB2 levels and AA-induced TxB2 formation was also studied in 71 patients out of entire population. Consistent with recommendations in the literature, we defined HAPR by setting a cut-off point at 3.1?ng/ml for serum levels of thromboxane B2 and 20% for AA-induced platelet aggregation. According to this cut-off point, we divided our overall population into two groups: (1) TxB2?<?3.1?ng/ml and (2) TxB2?>?3.1?ng/ml. We found low agreement between such tests to identify patients displaying HAPR. Our results show that AA-induced platelet aggregation >20% identify a smaller number of HAPR patients in comparison with TxB2. A good correlation between serum TxB2 and arachidonic acid-induced TxB2 production was found (r?=?0.76619). 相似文献
132.
133.
134.
135.
Extensive research has indicated that miRNAs are crucial for the occurrence and progression of cancers. miR-451a, involved in breast cancer (BC), is one of the miRNAs. This study focused on the mechanism by which miR-451a regulates BC. The levels of miR-451a in BC tissues and cell lines were examined using quantitative real-time polymerase chain reaction (qRT-PCR). Kaplan‒Meier analysis showed that this was intimately related to the patient's overall survival rate. Functional experiments revealed the negative effects of miR-451a on the abilities of BC cells to multiply (tested by Cell Counting Kit-8), migrate (tested by wound healing assay), and invade (tested by Transwell assay) and its positive effects on apoptosis (tested by flow cytometry). Western blotting indicated that the expression of tumor-related proteins was affected by miR-451a. Moreover, in vivo experiments suggested that tumor growth was clearly restrained by an miR-451a agonist in a xenograft tumor model. Bioinformatic analysis indicated that miR-451a directly targeted Cyclin D2 (CCND2), as demonstrated by the luciferase reporter assay. An opposite change in the level of CCND2 and miR-451a in BC was indicated by qRT-PCR, western blotting, and immunohistochemistry. Subsequently, functional experiments and western blotting analysis confirmed that CCND2 accelerated BC progression, which was regulated by miR-451a. Cumulatively, research on miR-451a may be valuable for BC treatment. 相似文献
136.
137.
目的 探讨血清谷丙转氨酶(ALT)与新诊2型糖尿病(T2DM)患病风险之间的关联,为T2DM的防治提供科学依据。方法 采用4阶段分层随机抽样的方法选取2006年和2009年参与青岛糖尿病预防项目的研究对象男性3 012例、女性4 422例,采用Pearson相关检验分析不同性别ALT与FPG、2 h PG的相关性,并利用多因素logistic回归分析ALT与新诊T2DM患病的关系。结果 男性中,ALT与空腹血浆血糖(FPG)、餐后2 h血浆血糖(2 h PG)的Pearson相关系数分别为0.088、0.080(均P<0.01);多因素logistic回归显示,在调整了年龄、BMI、糖尿病家族史、城乡、教育、婚姻、收入、吸烟及饮酒状况等混杂因素后,ALT的第4分位(Q4)组新诊T2DM患病风险是第1分位(Q1)组的1.832倍(OR = 1.832,95% CI:1.324~2.534,P<0.01)。女性中,ALT与FPG、2h PG的Pearson相关系数分别为0.065、0.108(均P<0.01);多因素logistic回归显示,在调整了年龄、BMI、糖尿病家族史、城乡、教育、婚姻、收入、吸烟及饮酒状况等混杂因素后,ALT的第4分位(Q4)组新诊T2DM患病风险是第1分位(Q1)组的1.445倍(OR = 1.445,95% CI:1.087~1.919,P<0.05)。结论 在男、女性人群中,ALT水平升高与T2DM患病相关,且这种相关性不受年龄、BMI、糖尿病家族史等的影响。 相似文献
138.
F. Murina R. Felice S. Di Francesco L. Nelvastellio I. Cetin 《Gynecological endocrinology》2020,36(5):431-435
AbstractThis study is a single-center, retrospective analysis of postmenopausal women presenting with dyspareunia and vulvar pain, aiming to evaluate relative effectiveness of vestibular CO2 laser therapy as a treatment. Three monthly sessions of laser were performed to each patient and thereafter a three-months follow-up was stablished. A total number of 72 patients undergoing vestibular laser treatment were recruited from patient files in the period between 2016 and 2018. Among these, 39 women also received a concomitant treatment with ospemifene (60?mg/day) during the study period. There was a statistically significant reduction of all the symptoms in both groups up to the three month follow-up. Regarding dryness and dyspareunia, the relief tent to be more prominent in the ospemifene?+?laser group at all follow-ups and remained statistically significant at three-month follow-up. Specifically, vestibular dryness was significantly lower in the ospemifene?+?laser group compared with the laser treatment group (?87% vs???34%, respectively), and the vestibular health score started declining faster in the ospemifene?+?laser group. Although, additional research is needed to understand the mechanism of action, our data shows that a combination regimen of laser and ospemifene may improve clinical effectiveness for long-term treatment of symptoms associated with the under-recognized genitourinary syndrome of menopause. 相似文献
139.
140.